Summary
This study protocol examines morning light therapy as a potential treatment for traumatic stress, with amygdala reactivity identified as a key mechanistic target to understand dose-response relationships. The findings could inform lighting design recommendations for therapeutic settings aimed at supporting individuals with PTSD or trauma-related conditions.
Key Findings
- Study protocol only — no outcome data reported; designed to identify mechanistically relevant targets and effective doses of morning light for traumatic stress treatment
- Amygdala reactivity is proposed as a primary neurological biomarker to assess the efficacy of morning light therapy for traumatic stress sequelae
Categories
Mood & Mental Wellness: Study protocol investigates morning light therapy as a treatment for traumatic stress, targeting amygdala reactivity as a mechanistic pathway.
Sleep & Circadian Health: Morning light treatment is examined for its role in circadian entrainment as a potential mechanism underlying therapeutic effects on traumatic stress.
Author(s)
DP Cenkner, HJ Burgess, B Huizenga, ER Duval
Publication Year
2022
Number of Citations
2
Related Publications
Mood & Mental Wellness
- The two‐process model of sleep regulation: a reappraisal
- Protecting the melatonin rhythm through circadian healthy light exposure
- Effects of artificial dawn and morning blue light on daytime cognitive performance, well-being, cortisol and melatonin levels
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- The role of daylight for humans: gaps in current knowledge
Sleep & Circadian Health
- Phototransduction by retinal ganglion cells that set the circadian clock
- The mammalian circadian timing system: organization and coordination of central and peripheral clocks
- The two‐process model of sleep regulation: a reappraisal
- Melanopsin is required for non-image-forming photic responses in blind mice
- Strange vision: ganglion cells as circadian photoreceptors